Medistim ASA 2022 AR2
The report highlights Medistim's record-breaking financial performance in 2022, achieving an all-time high in sales of MNOK 491.9 and a record EBIT of MNOK 141.2. The company experienced significant growth in its imaging product portfolio, which grew by 44%, and its vascular segment, which grew by 27.3%. Medistim expanded its global footprint, increasing its installed base to 3,300 systems across more than 65 countries. On the sustainability front, the company conducted a materiality assessment, aligned its operations with the UN Sustainable Development Goals, and successfully eliminated plastic bags from its probe packaging.
Company: Medistim ASA
Sector: Manufacturing
Country: Norway
Year: 2022
Type: AR2
Pages: 105
Back to company
Medistim ASA
Corporate Annual Report
The report highlights Medistim's record-breaking financial performance in 2022, achieving an all-time high in sales of MNOK 491.9 and a record EBIT of MNOK 141.2. The company experienced significant growth in its imaging product portfolio, which grew by 44%, and its vascular segment, which grew by 27.3%. Medistim expanded its global footprint, increasing its installed base to 3,300 systems across more than 65 countries. On the sustainability front, the company conducted a materiality assessment, aligned its operations with the UN Sustainable Development Goals, and successfully eliminated plastic bags from its probe packaging.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees